Natera

Strategic Account Manager (US - East Coast)

United States

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
AI & Machine Learning, Consumer Software, Financial ServicesIndustries

Requirements

Candidates should have a proven track record in account management, particularly with large enterprise clients. Experience in managing FTSE 100 and Fortune 500 accounts is essential. Strong relationship-building skills with senior executives are required, along with a creative approach to driving technology adoption within large organizations.

Responsibilities

The Strategic Account Manager will manage a portfolio of large enterprise customer accounts across the UK, US, and Europe. They will work alongside the CEO and other leadership to drive revenue growth and build strong client relationships. Responsibilities include engaging with high-profile clients, presenting to C-Suite executives, and collaborating with Customer Success and Sales teams to ensure successful onboarding and retention.

Skills

Account Management
SaaS
Relationship Building
Communication
Interpersonal Skills
Executive Communication
Client Relationship Management
Sales

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Key Metrics

Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Flexible medical plans
Investment options
Time off
Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
New Prospera Heart features may face slow adoption by healthcare providers.
Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
AI integration enhances accuracy and speed of Natera's cfDNA analysis.
Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI